[1]徐佳薇,汪洋,胡代玉.结核病患者服药依从性的影响因素及其促进措施[J].中国社会医学杂志,2007,24(2):135-137.[2] IUATLD/WHO. The promise and reality of fixed-dose combinations with rifampicin[J]. International Journal of Tuberculosis and Lung Disease, 1994, 75:180-181.[3] World Heath Organization Tuberculosis Program. Treatment of tuberculosis guidelines for national programs[S]. Geneva: WHO, 1993.[4] Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication Adherence Measure for Hypertension Control[J]. Journal of Clinical Hypertension 2008, 10(5):348-354.[5] 康华,蒋晓莲.肺结核病人服药依从性的研究进展[J].护理学杂志,2004,19(15):76-78.[6] Hong Kong Chest Service/British Medical Research Council.Acceptability,compliance,and adverse reactions when isoniazid,rifampin,and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy[J].Am Rev Respir Dis.1989,140(6):1618-22.[7] 谭卫国,杨应周,程锦泉,吴清芳,张玉华,罗育希,严薇荣,解瑞谦,钟球,王甦民.固定复合制剂治疗肺结核患者依从性分析[J].中国行为医学科学,2005,14(6):535-536.[8] 贺永鸿,成诗明,陈诚.固定剂量复合剂治疗肺结核患者依从性调查与分析[J].中国防痨杂志,2006,28(3):129-132.[9] Morisky DE,Green LW,Levine DM.Concurrent and predictive validity of a self-report measure of medication adherence[J].Med Care,1986,24:67-74. |